☰

Elaine Chen - Publications

Affiliations: 
2019- Pathology, Microbiology and Immunology Vanderbilt University School of Medicine, Nashville, TN, United States 
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wall SC, Suryadevara N, Kim C, Shiakolas AR, Holt CM, Irbe EB, Wasdin PT, Suresh YP, Binshtein E, Chen EC, Zost SJ, Canfield E, Crowe JE, Thompson-Arildsen MA, Sheward DJ, et al. SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes. Cell Reports. Medicine. 101267. PMID 37935199 DOI: 10.1016/j.xcrm.2023.101267  0.78
2023 Chen EC, Gilchuk P, Zost SJ, Ilinykh PA, Binshtein E, Huang K, Myers L, Bonissone S, Day S, Kona CR, Trivette A, Reidy JX, Sutton RE, Gainza C, Diaz S, et al. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Reports. 42: 112370. PMID 37029928 DOI: 10.1016/j.celrep.2023.112370  0.821
2022 Desautels TA, Arrildt KT, Zemla AT, Lau EY, Zhu F, Ricci D, Cronin S, Zost SJ, Binshtein E, Scheaffer SM, Engdahl TB, Chen E, Goforth JW, Vashchenko D, Nguyen S, et al. Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants. Biorxiv : the Preprint Server For Biology. PMID 36324800 DOI: 10.1101/2022.10.21.513237  0.781
2022 Gupta N, Marquez S, Soto C, Chen EC, Bostick ML, Stervbo U, Farmer A. Bulk Sequencing from mRNA with UMI for Evaluation of B-Cell Isotype and Clonal Evolution: A Method by the AIRR Community. Methods in Molecular Biology (Clifton, N.J.). 2453: 345-377. PMID 35622335 DOI: 10.1007/978-1-0716-2115-8_19  0.312
2021 Dong J, Zost SJ, Greaney AJ, Starr TN, Dingens AS, Chen EC, Chen RE, Case JB, Sutton RE, Gilchuk P, Rodriguez J, Armstrong E, Gainza C, Nargi RS, Binshtein E, et al. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail. Nature Microbiology. PMID 34548634 DOI: 10.1038/s41564-021-00972-2  0.841
2021 Chen EC, Gilchuk P, Zost SJ, Suryadevara N, Winkler ES, Cabel CR, Binshtein E, Chen RE, Sutton RE, Rodriguez J, Day S, Myers L, Trivette A, Williams JK, Davidson E, et al. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals. Cell Reports. 109604. PMID 34411541 DOI: 10.1016/j.celrep.2021.109604  0.775
2021 Gilchuk P, Guthals A, Bonissone SR, Shaw JB, Ilinykh PA, Huang K, Bombardi RG, Liang J, Grinyo A, Davidson E, Chen EC, Gunn BM, Alter G, Saphire EO, Doranz BJ, et al. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma. Frontiers in Immunology. 12: 706757. PMID 34335620 DOI: 10.3389/fimmu.2021.706757  0.56
2021 Zost SJ, Dong J, Gilchuk IM, Gilchuk P, Thornburg NJ, Bangaru S, Kose N, Finn JA, Bombardi R, Soto C, Chen EC, Nargi RS, Sutton RE, Irving RP, Suryadevara N, et al. Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface. The Journal of Clinical Investigation. PMID 34156974 DOI: 10.1172/JCI146791  0.67
2021 Chen EC, Gilchuk P, Zost SJ, Suryadevara N, Winkler ES, Cabel CR, Binshtein E, Sutton RE, Rodriguez J, Day S, Myers L, Trivette A, Williams JK, Davidson E, Li S, et al. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals. Biorxiv : the Preprint Server For Biology. PMID 33972937 DOI: 10.1101/2021.05.02.442326  0.775
2021 Suryadevara N, Shrihari S, Gilchuk P, VanBlargan LA, Binshtein E, Zost SJ, Nargi RS, Sutton RE, Winkler ES, Chen EC, Fouch ME, Davidson E, Doranz BJ, Chen RE, Shi PY, et al. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. PMID 33773105 DOI: 10.1016/j.cell.2021.03.029  0.813
2021 Dong J, Zost SJ, Greaney AJ, Starr TN, Dingens AS, Chen EC, Chen RE, Case JB, Sutton RE, Gilchuk P, Rodriguez J, Armstrong E, Gainza C, Nargi RS, Binshtein E, et al. Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail. Biorxiv : the Preprint Server For Biology. PMID 33532768 DOI: 10.1101/2021.01.27.428529  0.837
2021 Suryadevara N, Shrihari S, Gilchuk P, VanBlargan LA, Binshtein E, Zost SJ, Nargi RS, Sutton RE, Winkler ES, Chen EC, Fouch ME, Davidson E, Doranz BJ, Carnahan RH, Thackray LB, et al. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Biorxiv : the Preprint Server For Biology. PMID 33501445 DOI: 10.1101/2021.01.19.427324  0.813
2020 Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RE, Nkolola JP, Schäfer A, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Martinez DR, Williamson LE, Chen EC, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. PMID 32668443 DOI: 10.1038/S41586-020-2548-6  0.825
2020 Zost SJ, Gilchuk P, Chen RE, Case JB, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Chen EC, Binshtein E, Shrihari S, Ostrowski M, Chu HY, Didier JE, et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nature Medicine. PMID 32651581 DOI: 10.1038/S41591-020-0998-X  0.836
2020 Chen EC, Rubinstein S, Soto C, Bombardi RG, Day SB, Myers L, Zaytsev A, Majedi M, Cornell RF, Crowe JE. Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosis. Plos One. 15: e0235713. PMID 32634163 DOI: 10.1371/Journal.Pone.0235713  0.337
2020 Zost SJ, Gilchuk P, Chen RE, Case JB, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Chen EC, Binshtein E, Shrihari S, Ostrowski M, Chu HY, Didier JE, et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Biorxiv : the Preprint Server For Biology. PMID 32511414 DOI: 10.1101/2020.05.12.091462  0.835
2020 Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RE, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Williamson LE, Chen EC, Jones T, Day S, Myers L, et al. Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals. Biorxiv : the Preprint Server For Biology. PMID 32511409 DOI: 10.1101/2020.05.22.111005  0.83
Show low-probability matches.